Nanfang Hospital of Southern Medical University

Guangdong, Guangzhou 510515

1 studies enrolling now · 2 studies all time

What they study most

Candidemia, Candidiasis, Invasive, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Ph+ ALL

Studies at this site

• A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1) — Recruiting now
• A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole — Stopped early